Dorff, T. B., Quinn, D. I., Pinski, J. K., Goldkorn, A., Sadeghi, S., Tsao-Wei, D., . . . Gross, M. E. (2019). Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC). Clin Genitourin Cancer.
Chicago Style citaatDorff, Tanya B., David I. Quinn, Jacek K. Pinski, Amir Goldkorn, Sarmad Sadeghi, Denice Tsao-Wei, Susan Groshen, Peter Kuhn, en Mitchell E. Gross. "Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC)." Clin Genitourin Cancer 2019.
MLA citatieDorff, Tanya B., et al. "Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC)." Clin Genitourin Cancer 2019.